Introduction Semaglutide, a medication initially developed for the treatment of type 2 diabetes, has emerged as a breakthrough in managing obesity and improving cardiovascular health. As a member of the GLP-1 receptor agonist class, Semaglutide mimics a natural hormone in the body that helps regulate blood sugar, suppress appetite, and https://dna-based-fitness-test08630.wikijm.com/1094674/semaglutide_a_revolutionary_treatment_for_diabetes_obesity_and_cardiovascular_health